Balanced Regulation of mRNA Production for Fas and Fas Ligand in Lymphocytes From Centenarians: How the Immune System Starts Its Second Century

Background—The functionality of the immune system during aging is crucial for protection against the most common age-related diseases. Apoptosis plays a central role in the senescence of the immune system, as evidenced by the increased plasma membrane expression of a key molecule like Fas protein. We analyzed the mRNA levels of different forms of Fas (total [tFas] and membrane [mFas]) and of its ligand (FasL) in peripheral blood lymphocytes from centenarians, the best example of successful aging, who were compared with young and middle-aged donors. Methods and Results—Using real-time polymerase chain reaction, we quantified mRNA for different forms of Fas and for FasL. In resting lymphocytes, mRNA for tFas, but not for mFas, significantly increases with age, whereas FasL mRNA significantly decreases. In vitro production of Fas/FasL mRNA after different stimuli was similar in cells from the 3 groups. Even if the percentage of Fas+ cells was higher than in the other groups, peripheral blood lymphocytes from centenarians had normal Fas-induced apoptosis, as revealed by flow cytometry. By ELISA, we observed that cells from centenarians showed normal in vitro production of the soluble form of Fas (sFas) and that plasma levels of such molecule were significantly higher in centenarians than in the other groups. Conclusions—Lymphocytes from centenarians are able to balance the production of proapoptotic (mFas and FasL) and antiapoptotic (sFas) molecules, whose proportions are likely crucial for the well-preserved immune functionality at the extreme limits of human life.

[1]  G. D'offizi,et al.  Highly Active Antiretroviral Therapy Restores CD4+ V&bgr; T-Cell Repertoire in Patients With Primary Acute HIV Infection But Not in Treatment-Naive HIV+ Patients With Severe Chronic Infection , 2004, Journal of acquired immune deficiency syndromes.

[2]  C. Mussini,et al.  Different Sensitivity to Apoptosis in Cells of Monocytic or Lymphocytic Origin Chronically Infected with Human Immunodeficiency Virus Type-1 , 2003, Experimental biology and medicine.

[3]  G. Salvioli,et al.  Development of real time PCR assays for the quantification of Fas and FasL mRNA levels in lymphocytes: studies on centenarians , 2003, Mechanisms of Ageing and Development.

[4]  Y. Higami,et al.  Impact of aging and life‐long calorie restriction on expression of apoptosis‐related genes in male F344 rat liver , 2002, Microscopy research and technique.

[5]  G. Salvioli,et al.  Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians , 2002, Cell Death and Differentiation.

[6]  B. Herman,et al.  Ageing and apoptosis , 2002, Mechanisms of Ageing and Development.

[7]  M. Kinoshita,et al.  Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure. , 2001, Journal of cardiac failure.

[8]  T. Majima,et al.  Plasma soluble Fas ligand concentration: decrease in elderly men and increase in patients with gastric carcinoma. , 2001, Oncology reports.

[9]  C. Franceschi,et al.  Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians , 2001, Mechanisms of Ageing and Development.

[10]  C. Mussini,et al.  Quantitation of CD95 and CD95L mRNA Expression in Chronic and Acute HIV‐1 Infection by Competitive RT‐PCR , 2000, Annals of the New York Academy of Sciences.

[11]  C. Franceschi,et al.  Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. , 2000, Blood.

[12]  S. Valensin,et al.  Do men and women follow different trajectories to reach extreme longevity? , 2000, Aging.

[13]  T. Miyakawa,et al.  Role of Blood Vessels in Producing Pathological Changes in the Brain with Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[14]  C. Franceschi,et al.  Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. , 2000, Vaccine.

[15]  S. Nagata,et al.  Fas ligand-induced apoptosis. , 1999, Annual review of genetics.

[16]  G. Pawelec,et al.  Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes☆ , 1999, Experimental Gerontology.

[17]  K. Nishigaki,et al.  An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. , 1998, Respiratory medicine.

[18]  S. Aggarwal,et al.  Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. , 1998, Journal of immunology.

[19]  G. Pawelec,et al.  T cells and aging. , 1998, Frontiers in bioscience : a journal and virtual library.

[20]  T. Koji,et al.  Aging accelerates but life-long dietary restriction suppresses apoptosis-related Fas expression on hepatocytes. , 1997, The American journal of pathology.

[21]  S. Boutet,et al.  Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of functional Fas receptors , 1997, Mechanisms of Ageing and Development.

[22]  C. Franceschi,et al.  Cytometric analysis of immunosenescence. , 1997, Cytometry.

[23]  V. Depraetere,et al.  Fas and other cell death signaling pathways. , 1997, Seminars in immunology.

[24]  G. Starace,et al.  An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. , 1996, Journal of immunology.

[25]  Gastone Castellani,et al.  CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: implications for T cell memory , 1996, Mechanisms of Ageing and Development.

[26]  J. Campisi,et al.  Replicative Senescence: An Old Lives' Tale? , 1996, Cell.

[27]  J. Mountz,et al.  Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. , 1995, The Biochemical journal.

[28]  E. Wang,et al.  Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. , 1995, Cancer research.

[29]  G. Fiucci,et al.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.

[30]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[31]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[32]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.

[33]  C. Franceschi,et al.  Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.

[34]  C. Franceschi,et al.  The immunology of exceptional individuals: the lesson of centenarians. , 1995, Immunology today.